ESC Professional Premium Access

Do female patients with hypertrophic cardiomyopathy have a worse prognosis than male patients?

Congress Presentation

About the speaker

Doctor Veronika Puchnerova

Motol University Hospital, Prague (Czechia)
0 follower

7 more presentations in this session

Ventricular activation time as a marker for complex ventricular arrhythmias, sudden cardiac death and ICD implantation in hypertrophic cardiomyopathy

Speaker: Doctor K. Fragkiadakis (Heraklion, GR)


Predictors of left ventricular dysfunction in hypertrophic cardiomyopathy: results from a nationwide registry

Speaker: Doctor M. Brandao (Vila Nova de Gaia, PT)


Exercise unmasks impaired vascular and cardiac hemodynamic in patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Tamargo (Madrid, ES)


Genotype-phenotype correlation and allele dating analysis of a novel variant in hypertrophic cardiomyopathy: p.Arg652Lys in MYH7

Speaker: Mr G. Antoniutti (Palma de Mallorca, ES)


The impact of adrenoceptor-1 gene polymorphism on structural and functional features in patients with hypertrophic cardiomyopathy

Speaker: Doctor D. Raimoglou (Istanbul, TR)


Access the full session

Insights in hypertrophic cardiomyopathy and Chagas‘ disease

Speakers: Doctor V. Puchnerova, Doctor K. Fragkiadakis, Doctor M. Brandao, Doctor M. Tamargo, Mr G. Antoniutti...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb